FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain
FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain Print this page MALVERN, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA)… Read More »